Trade Summary

5 days ago, Barchas Isaac, serving as Dir at Immunome Inc. (IMNM), sold 36,088 shares at $26.06 per share, for a total transaction value of $940,453.28. Following this transaction, Barchas Isaac now holds 72,416 shares of IMNM.

This sale represents a 33.26% decrease in Barchas Isaac's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 4:10 PM ET, 4 days after the trade was made.

Immunome Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.